Skip to main content
. 2017 Dec 22;8:933. doi: 10.3389/fphar.2017.00933

FIGURE 2.

FIGURE 2

The effects of CP-25 on B cell proliferation stimulated by BAFF and TNF-alpha. B cells were stimulated with BAFF (100 ng/ml) (A) and TNF-alpha (100 ng/ml) (B) for 2 h, and then were treated with CP-25 (10-5 mol/l) or Rituximab (5 μg/ml) or Etanercept (10 μg/ml). After incubation for 48 h. B cell proliferation is assayed using the CCK-8 method. Bar graphs show the values of absorbance (450 nm) in different groups. Data are presented as mean ± SD (n = 5). P < 0.05 versus control group. ##P < 0.01 versus BAFF/TNF-alpha group.